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We performed holmium laser enucleation of the prostate (HoLEP) on 98 patients between February
2005 and February 2007. Seventy ﬁve patients with the mean age of 68.9 (ranging 55-84) were assessed
preoperatively and followed up at 1, 3 and 12 months postoperatively. Before and after HoLEP,
International Prostate Symptom Score (IPSS), quality of life (QOL) index, maximum ﬂow rate (Qmax) and
post-void residual (PVR) urine were all improved signiﬁcantly (p＜0.001). When urinary incontinence was
strictly deﬁned as International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) scores
B1, incontinence was observed in 71％ of patients preoperatively. ICIQ-SF scores were increased from 5.2
preoperatively to 8.0 at 1 month postoperatively, but improved thereafter and had decreased signiﬁcantly to
2.5 (p＜0.05 compared with baseline) at 12 months. Univariate and multivariate logistic regression analysis
revealed date of operation and operation time were signiﬁcantly (p＜0.05) correlated with postoperative stress
urinary incontinence (SUI) at 1 month and enucleated volume was of borderline signiﬁcance (p＝0.052) at 12
months. In terms of sexual function, mean IIEF5 scores were not signiﬁcantly changed, but we could
classify the scores into ﬁve types of response-unchanging (64%), improving (13%), worsening (11%), transient
worsening (9%) and unclassiﬁed (2%). HoLEP is an effective treatment for BPH. Urinary incontinence
improved by 1 year. HoLEP does not appear to affect sexual function, but various clinical courses were
observed.
(Hinyokika Kiyo 55 : 539-543, 2009)












当院では2005年 2月より HoLEP を導入しており，
今回術後 1年目までの排尿状態および尿失禁・性機能
の推移を調べたので報告する．
対 象 と 方 法









社製 Versa Pulse Select，レーザーファイバーは Slim
Line 550 μm，照射条件は 80 W 以下とし，内視鏡は
Olympus 社製 26 Fr レーザー用持続灌流式内視鏡，組
織細切器は Lumenis 社製 Versa Cut System，Storz 社製
腎盂鏡を用いた．










目は排尿状態に関して尿流測定 (uroﬂowmetry : UFM)
による最大尿流量 (Qmax），残尿量 (post void residual
urine : PVR），国際前立腺症状スコア (International
Prostate Symptom Score : IPSS），quality of life (QOL)
index，尿失禁に関して国際禁制学会尿失禁質問票短
縮版 ICIQ-SF (International Consultation on Inconti-
nence Questionnaire-Short Form），性機能に関して簡易
版国際勃起機能スコア (International Index of Erectile









統計学的検定には SPSS II for Windows を使用し，





均 36.7 (5.6∼125) g であった．
術後 1年目までの排尿に関する結果を Table 2 に示
















Table 1. Patient characteristics and operative data
No pts 75
Age [yr] 68.9± 7.3 (55- 84)
Estimated prostate volume [ml] 63.9± 26.2 (23-140)
IPSS 22.0± 7.8 ( 0- 35)
QOL index 4.8± 1.2 ( 0- 6)
Peak ﬂow rate (Qmax) [ml/s] 7.8± 3.1 (1.7-16.6)
Postvoid residual (PVR) [ml] 114.2±116.2 ( 0-782)
Total PSA [ng/ml] 8.1± 6.7 (0.8-35.6)
Operating time [min] 199.8± 74.3 (58-420)
Enucleated Volume [gm] 36.7± 23.1 (5.6-125 )
Means±standard deviation (range).
Table 2. Urinary function following HoLEP
Baseline (n＝75) 1 M (n＝72) 3 M (n＝71) 12 M (n＝53)
IPSS 22.0± 7.8 (0 - 35 ) 10.5± 7.1* (0 - 29 ) 7.7± 5.4* (0 - 34 ) 5.7± 4.8* (0 - 21 )
QOL index 4.8± 1.2 (0 - 6 ) 2.6± 1.8* (0 - 6 ) 2.0± 1.6* (0 - 6 ) 1.5± 1.5* (0 - 6 )
Qmax 7.8± 3.1 (1.7- 16.6) 14.9±10.0* (3.0- 52.6) 16.2± 9.3* (1.0- 50.9) 19.3±11.4* (1.9- 63.3)
PVR 114.2±116.2 (0 -782 ) 33.5±36.5* (0 -192 ) 28.1±29.2* (0 -150 ) 26.1±40.0* (0 -239 )
* p＜0.001 compared with baseline. Means±standard deviation (range).
泌55,09,02-1
Fig. 1. Perioperative changes of ICIQ-SF scores.
泌55,09,02-2
Fig. 2. Perioperative prevalence of 4 types of
incontinence.





の (p＝0.052) 相関関係の傾向にあった (Table 3）．
次に性機能に関しては術前の IIEF5 が分かっており
術後 2回以上評価を行った53例を対象とした．術前に
IIEF5 で 7点以下の重度 ED (erectile dysfunction) 症例











化型 6例（11％），一時悪化型 5例（ 9％），分類不能































（28％），24名（32％）， 7 名（ 9％）であった．尿失
泌55,09,02-3
Fig. 3. Perioperative changes of IIEF5 scores.
Table 3. Univariate and multivariate analysis of risk factors for postoperative SUI
1 M 3 M 12 M
Univariate Multivariate Univariate Multivariate Univariate Multivariate
Age 0.74 ― 0.53 ― 1.0 ―
Body weight 0.27 ― 0.18 0.18 0.22 0.31
Total PSA 0.52 ― 0.87 ― 0.75 ―
IPSS 0.56 ― 0.88 ― 0.92 ―
Estimated prostate volume 0.97 ― 0.23 0.11 0.13 0.13
Uroﬂow variables
Voided volume 0.21 0.21 0.066 0.078 0.37 ―
Qmax 0.34 ― 0.84 ― 0.46 ―
PVR 0.12 0.20 0.34 ― 0.88 ―
Date of operation 0.043 0.04* 0.39 ― 0.43 ―
Operation time 0.037 0.029* 0.11 0.097 0.12 0.17
Enucleated volume 0.91 ― 0.29 ― 0.093 0.052
Urethral stricture 0.99 ― 0.19 0.33 0.39 ―
* P＜0.05.


















下部尿路症状 (LUTS) と勃起不全 (ED) の間に強
い関連があることはすでに大規模な疫学調査で証明さ
れており，前立腺肥大症は LUTS だけでなく ED に
も関与している8)．加えて前立腺肥大症治療の副作用
による ED も報告されており，TUR-P 後 2∼10％に






















Fig. 4. a : IIEF5 : Unchanging scores (n＝34). b : IIEF5 : Improving scores (n＝7). c : IIEF5 : Worsening
scores (n＝6). d : IIEF5 : Transient worsening scores (n＝5). e : IIEF5 : Unclassiﬁed (n＝1).
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